PIRAZIDOL (Lifril, Pirlindole) is a potent antidepressant that was developed to treat depressions associated with psychomotor retardation and asthenic disorders, accompanied by anxiety-depressive and anxious-delirious components, anesthetic, hypochondriac and neurosis-like symptoms; senile, involutional depression; depressive and anxious-depressive states in alcohol-dependent patients, especially during the abstinence.
Eliminate Asthenic Disorders
Combat Alzheimer’s Disease
Relieve Alcohol Withdrawal Syndrome
GUARANTEE & EXPIRY DATE
100% Original from the Russian Pharmstandard.
Pyrazidol contains the active substance – pirlindole – a timoleptic, antidepressant. Selectively inhibits MAO type A, blocks deamination of serotonin and norepinephrine, to a lesser extent – tyramine. Selectively inhibits the reuptake of monoamines, potentiates the effects of the predecessor of norepinephrine-dioxyphenylalanine (L-dopa) and the precursor of serotonin-5-hydroxytryptophan. Stimulates adreno-and serotonergic structures. Activates the processes of synaptic transmission of nervous excitation in the central nervous system.
Further read: https://en.wikipedia.org/wiki/Pirlindole
PACKAGING & DOSAGE
Active substance: pirlindol
Excipients: lactose, starch, calcium stearate.
The initial dose is 50-100mg 2 times per day, the dose is gradually increased by 50mg to 150-300mg/day. The maximum recommended dose is 400mg/day, divided into 2 parts. After the therapeutic effect has been achieved the treatment should be maintained during 2-4 weeks, after that the dose is gradually reduced.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.